MSLN and mesothelioma: The new protein, which contains a large deletion of domain II and 10 amino acid mutations in domain III, is very cytotoxic to mesothelioma cells as well as other cancer cell lines, is well tolerated by mice and produces complete remissions of mesothelin expressing cancers in mice.